Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Pneumococcal Vaccine Market Forecast: Value Set To Climb From $9.93 Billion To $12.76 Billion
The pneumococcal vaccine market size has experienced significant expansion over recent years. It is anticipated to increase from $9.4 billion in 2025 to $9.94 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. The market’s historic growth can be linked to the substantial burden of childhood pneumonia, its inclusion in national immunization programs, strong support from global health organizations, increasing awareness of invasive pneumococcal disease, and the proven efficacy of PCV vaccines.
The pneumococcal vaccine market is projected to experience substantial expansion over the coming years, with its size set to reach $12.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This anticipated growth during the forecast period is driven by several factors, including the introduction of advanced PCV vaccines, wider adult vaccination guidelines, improved healthcare accessibility in developing nations, escalating worries about antimicrobial resistance, and governmental support for preventative immunization initiatives. Key trends expected in this period involve the development of conjugate vaccines to cover a broader range of serotypes, a heightened emphasis on immunization programs for children and the elderly, increasing use of combined and booster vaccination approaches, enhanced collaborations between public and private sectors for wider immunization coverage, and an expansion of preventive healthcare alongside national immunization calendars.
Get A Free Sample Report With In-Depth Market Insights:
Pneumococcal Vaccine Market Development Factors: What’s Supporting Demand?
The increasing incidence of pneumococcal contamination is anticipated to boost the growth of the pneumococcal vaccine market. Pneumococcal contamination refers to infections caused by *Streptococcus pneumoniae* bacteria, including conditions such as pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine works by prompting the body to generate antibodies against these bacteria, thereby reducing or eliminating disease-carrying pathogens and toxins to safeguard children, the elderly, and individuals with weakened immune systems from various pneumococcal infections. For example, in July 2025, the Immunisation Coalition, an independent not-for-profit charity based in Australia, reported a consistent rise in cases of invasive pneumococcal disease (IPD), increasing from 1,869 in 2022 to 2,265 in 2023, and reaching 2,379 in 2024. This growing prevalence of pneumococcal contamination is thus a significant driver for the expansion of the pneumococcal vaccine market.
Pneumococcal Vaccine Market Segmentation And Category Overview
The pneumococcal vaccine market covered in this report is segmented –
1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products
2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous
3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels
4) By End User: Pediatrics, Adults
Subsegments:
1) By Prevnar 13: Pediatric Formulation, Adult Formulation
2) By Synflorix: Pediatric Formulation, Adult Formulation
3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes
4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines
Pneumococcal Vaccine Market Transformation Trends: What Innovations Are Driving Change?
Key players within the pneumococcal vaccine market are developing novel offerings to enhance their market profitability. An example of this is the introduction of the V116 vaccine by Merck & Co Inc., a US-based pharmaceuticals company, in July 2023. This V116 vaccine aims to address the eight distinct serotypes of Streptococcus pneumoniae, which are largely accountable for adult pneumococcal disease. Demonstrating superior immunogenicity across multiple serotypes in adult populations when compared to existing pneumococcal vaccines, V116 has also elicited favorable immune responses in individuals who are both new to vaccination and those previously vaccinated. The U.S. Food and Drug Administration (FDA) has recognized V116 as a breakthrough therapy, and its development is presently in Phase 3.
Pneumococcal Vaccine Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the pneumococcal vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, PnuVax Incorporated, SK Bioscience Co Ltd, Bharat Biotech International Ltd, Medicago Inc., Emergent BioSolutions Inc., Valneva SE
View The Full Pneumococcal Vaccine Market Report:
Pneumococcal Vaccine Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the pneumococcal vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









